Cell and Gene Outsourcing

  1. From Platform To Patient: Streamlining Gene Therapy Development

    Explore how platform processes advance gene therapies, the impact of strong partnerships on patient access, and the future shaped by these collaborations.

  2. Quality Agreements: Defining Governance In CDMO Partnerships 5/15/2024

    Quality agreements serve a critical role within a CDMO-Sponsor partnership. Review the importance of aligning objectives, quality standards, and compliance frameworks to establish a robust foundation.

  3. Expertise In Commercial Fill-Finish For More Than 30 Years 8/5/2024

    Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.

  4. Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats

    Explore an integrated drug substance/drug product CMC strategy and technical case studies that provide insight into delivering product-specific solutions and enabling the acceleration of novel molecular formats.

  5. Optimizing Monoclonal Antibody Manufacturing For Commercial Success

    Strategically optimize your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.

  6. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

    Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

  7. Sustainable Approaches To Oligonucleotide Manufacturing

    An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.

  8. Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics

    In recent years, the number of biotherapeutic molecules requiring more complex assemblies has greatly increased. Typically, these multi-chain molecules are no longer compatible with platform approaches and require a more agile approach to early developability and method development.

  9. Optimizing Viability And Standardization For Clinical Excellence 10/2/2024

    Explore how IntegriCell™ delivers high-quality, manufacture-ready cryopreserved leukopaks, vital for consistent and reliable cell therapy production.

  10. Cryopreservation Best Practices For Cell & Gene Therapy Source Material 2/26/2024

    Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.